HARNESSING CT041 CAR T CELLS AGAINST CLAUDIN18.2-EXPRESSING METASTATIC PANCREATIC TUMORS
Hiroshi Takumi Watanabe · August 2025 · pp. 18-20
Pancreatic cancer lacks effective therapy. Here, we reported two metastatic pancreatic cancer patients administrated with Claudin 18.2 (CLDN 18.2) CART therapy after the failure of standard therapy (NCT04581473 and NCT03874897)....